Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Freddy Frost

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 28, 2020
The clinical and microbiological utility of inhaled aztreonam lysine for the treatment of acute pulmonary exacerbations of cystic fibrosis: An open-label randomised crossover study (AZTEC-CF)Freddy Frost, Gregory R Young, Laura Wright, et al.
BMJ Open|March 25, 2025
Effects of azithromycin in young adults with cystic fibrosis: a protocol for emulating a published randomised controlled trial using registry dataEmily Granger, Jonathan Todd, Susan Christine Charman, et al.
Future Healthcare Journal|April 1, 2021
The rapid development and deployment of a new multidisciplinary CPAP service outside of a critical care environment during the early stages of the COVID-19 pandemicRyan E Robinson, Rebecca Nightingale, Freddy Frost, et al.
Annals of Emergency Medicine|June 12, 2023
HEART Score Recalibration Using Higher Sensitivity Troponin TAleem U Khand, Barbra Backus, Michael Campbell, et al.
The European Respiratory Journal|November 27, 2024
Cardiovascular benefits and safety profile of macrolide maintenance therapy in patients with bronchiectasisRan Guo, Dennis Wat, Steven Ho Man Lam, et al.
Journal of the American College of Cardiology|May 20, 2026
Accelerated Diagnostic Pathways for Suspected Acute Coronary Syndrome in Practice: A Randomized Trial of 0/1-Hour vs 0/3-Hour Troponin TestingJames Hatherley, Ahmed Dakshi, Paul Collinson, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 20, 2026
Determinants of early Elexacaftor-Tezacaftor-Ivacaftor use in adults with cystic fibrosis and preserved lung function: insights from a European multicenter surveyAndrea Gramegna, Carlo Magnoni, Chiara Premuda, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 28, 2020
The clinical and microbiological utility of inhaled aztreonam lysine for the treatment of acute pulmonary exacerbations of cystic fibrosis: An open-label randomised crossover study (AZTEC-CF)Freddy Frost, Gregory R Young, Laura Wright, et al.
BMJ Open|March 25, 2025
Effects of azithromycin in young adults with cystic fibrosis: a protocol for emulating a published randomised controlled trial using registry dataEmily Granger, Jonathan Todd, Susan Christine Charman, et al.
Future Healthcare Journal|April 1, 2021
The rapid development and deployment of a new multidisciplinary CPAP service outside of a critical care environment during the early stages of the COVID-19 pandemicRyan E Robinson, Rebecca Nightingale, Freddy Frost, et al.
Annals of Emergency Medicine|June 12, 2023
HEART Score Recalibration Using Higher Sensitivity Troponin TAleem U Khand, Barbra Backus, Michael Campbell, et al.
The European Respiratory Journal|November 27, 2024
Cardiovascular benefits and safety profile of macrolide maintenance therapy in patients with bronchiectasisRan Guo, Dennis Wat, Steven Ho Man Lam, et al.
Journal of the American College of Cardiology|May 20, 2026
Accelerated Diagnostic Pathways for Suspected Acute Coronary Syndrome in Practice: A Randomized Trial of 0/1-Hour vs 0/3-Hour Troponin TestingJames Hatherley, Ahmed Dakshi, Paul Collinson, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 20, 2026
Determinants of early Elexacaftor-Tezacaftor-Ivacaftor use in adults with cystic fibrosis and preserved lung function: insights from a European multicenter surveyAndrea Gramegna, Carlo Magnoni, Chiara Premuda, et al.
Pageof 4